Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and β 2-microglobulin, respectively

Clinical and Experimental Immunology

Volumn 122, Issue 1, 2000, Pages 79-84

  Lawn, S D ^a,c   Rudolph, D ^a   Wiktor, S ^a,b   Coulibaly, D ^a,b   Ackah, A ^a,b   Lal, R B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Project RETRO CI Abidjan   (Côte d’Ivoire)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Bgr>2 microglobulin; IV immune activation markers; NF receptors; Tuberculosis

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SERUM; TUBERCULOSIS; VIRUS INFECTION;

ADULT; ANTIGENS, CD; ANTITUBERCULAR AGENTS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUBERCULOSIS;

EID: 0033775971     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01341.x     Document Type: Article

References (40)

1. The double burden of HIV infection and tuberculosis in sub-Saharan Africa
2. Tuberculosis and HIV infection in sub-Saharan Africa
3. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia
4. Radiological features of pulmonary tuberculosis in West Africans coinfected with HIV Br J Radiol
5. Mycobacterium tuberculosis and its purified protein derivative activate expression of human immunodeficiency virus
6. Phagocytosis of Mycobacterium tuberculosis modulates human immunodeficiency virus replication in human monocytic cells
7. Mycobacterium tuberculosis enhances HIV-1 replication by transcriptional activation at the long terminal repeat
8. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
9. Cellular compartments of H1V-1 replication: Determination by virion-associated host proteins and the impact of opportunistic infection in vivo
10. Accelerated course of HIV infection after tuberculosis
11. Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology
12. Immune activation is a dominant factor in the pathogenesis of African AIDS
13. Influence of microbial infections on the progression of HIV disease
14. The effect of acute infectious illnesses on plasma human immunodeficiency virus type I load and the expression of serologic markers of immune activation among HIV-infected adults
15. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration
16. Sustained plasma TNF-α and HIV-1 load despite resolution of other immune activation parameters during treatment for tuberculosis in Africans
17. Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: A randomized, controlled trial
18. Immunological activation markers in the serum of African and European HIV-positive and - Seronegative individuals
19. Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV- 1 -infected patients from Ethiopia
20. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote D'Ivoire
21. + patients with tuberculosis in Africa: Prolonged elevation during anti-tuberculosis treatment
22. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection
23. Generalised immune activation in pulmonary tuberculosis: Coactivation with HIV infection
24. Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis
25. Extrapulmonary and disseminated tuberculosis in HIV-1 seropositive patients presenting to the acute medical services in Nairobi
26. M. tuberculosis enhances HIV-1 replication in the lung
27. Evolution of class-I MHC genes and proteins: From natural selection to thymic selection
28. Seropositivity for HIV and the development of AIDS or AIDS related condition: Three year follow up of the San Francisco General Hospital cohort
29. 2-microglobulin, and acute phase proteins in HIV-1 seropositive and -seronegative Zambian patients with tuberculosis
30. 2-microglobulin levels in HIV-1 positive and negative Tanzanian patients with tuberculosis
31. 2-microglobulin levels in HIV-seronegative and HIV-seropositive African patients with pulmonary tuberculosis
32. Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis
33. 2-microglobulin in HIV-1-associated tuberculosis
34. Shedding of the soluble form of CD8 complex by CD8+/HLA-DR+ cells in HIV-1 infected patients
35. Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease
36. Elevated concentrations of circulating ICAM-1 in far advanced and miliary tuberculosis
37. Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis
38. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation
39. Soluble tumour necrosis factor (TNF)-receptor levels in serum as markers of anti-viral host reactivity